|
| | 
|
 | |
        
|  |
 
|
 SANOFI - [Ticker: SAN.PA] |     | | Last Trade | 80.53 | Last Trade Time | 2017-11-01 - 21:36:00 | | Variation | -0.76 (-0.93%) | Open | 81.79 | | High | 81.99 | Low | 80.43 | | Volume | 2,902,429 | Average Volume (3m) | 0 | | Yield | | Bid / Ask | 71.12 x 1,000 - 71.74 x 44,000 | | Former Close | 81.29 | 52 Week Range | [0.00 - 0.00] | | PER | 0.00% | EPS | 0.00 | | Ex-Dividend Date | | Dividend Payment | | | Market Capitalization | 0 | 1 Year Price-Target | 0.00 | | Note: The data may have some minutes of delay. |
| | Watch more quotes |
| Last 10 Forum Topics about SANOFI: | | No topics about SANOFI [SAN.PA] have been found, but a search on the Forum for more topics related to SANOFI is advised. |
|
News about SANOFI [SAN.PA]: (ordered by relevance)
| | Amgen-Sanofi patent case divides makers of antibody drugs Reuters.com
The 'Truth Leaks Out': Justices Struggle with the Science, Sanofi ... IPWatchdog.com
Amgen-Sanofi patent case divides makers of antibody drugs Financial Post
Stock Watch: Sanofi, Pfizer And The Aftermath Of Acquisitions Scrip
COPD nod could be worth $3.5B for Sanofi, Regeneron's Dupixent FiercePharma
Sanofi SA (SNY) Up 1.18% in Premarket Trading InvestorsObserver
Sanofi launches new long-acting insulin drug in India Economic Times
The Zacks Analyst Blog Highlights Sanofi, Regeneron, AbbVie, Roche and Eli Lilly Yahoo Finance
Sanofi to cut US insulin prices by up to 78% in January 2024 PMLiVE
Could This Label Expansion Be a Growth Catalyst for Sanofi Stock? The Motley Fool
Sanofi/Regeneron?s Dupixent approved by EC for atopic dermatitis ... PMLiVE
Sanofi to acquire Provention Bio in deal worth $2.9bn PMLiVE
Sanofi to cut US price of its most-prescribed insulin by 78% Reuters.com
With 58% institutional ownership, Sanofi (EPA:SAN) is a favorite amongst the big guns Simply Wall St
Sanofi/Regeneron?s Dupixent shows promise in atopic hand and ... PMLiVE
Sanofi reports positive new data for multiple sclerosis treatment ... PMLiVE
Justices Wrestle With Amgen-Sanofi Patent Fight Over Repatha Bloomberg Law
Sanofi's site modernization spree rolls on with plan to shift 2000 ... FiercePharma
EPO revokes Amgen antibody patent amid ongoing battle with Sanofi JUVE Patent
Provention Bio: Sanofi Acquires Provention Bio With A 273 ... Seeking Alpha
Seagen goes to Pfizer for $43B; Sanofi buys diabetes partner ... Endpoints News
COPD trial data coming soon for Sanofi, Regneron's Dupixent FiercePharma
Bernie Sanders calls out Sanofi, Novo Nordisk for insulin prices FiercePharma
The IIIs have it! Sanofi's fresh approval of bleeding drug Altuviiio ... FiercePharma
Lilly Slashed Its Insulin Prices. Will Sanofi and Novo Nordisk Do the ... Managed Healthcare Executive
Sanofi Could Be on a Roll With a Strong Performance and Its Latest ... The Motley Fool
Sanofi launches its first smart data sensor that records insulin ... BioWorld Online
Sanofi: Phase-3 study on Hemophilia A treatment met primary ... Reuters.com
Successful transaction: Adragos Pharma has officially taken over the ... RealWire
In SCOTUS filing, Amgen claps back at Sanofi and Regeneron in ... FiercePharma
Regeneron, Sanofi's Kevzara nabs polymyalgia rheumatica FDA nod FiercePharma
Sanofi invests in successful Geisinger Commonwealth REACH-HEI ... Geisinger
Vaccine patch maker Vaxess names former Sanofi exec as chief ... Drug Delivery Business News
Sanofi Stock: Pharma Tees Up To Rival Pfizer In RSV Vaccine Battle ... Investor's Business Daily
Alumni @ RopesTalk: Conversation with Beibei Sun, Sanofi Ropes & Gray LLP
Junshi's lipid lowering drug hits phase 3 goals, teeing up challenge ... FierceBiotech
Cold Pain Therapy Market (2023 ? 2030)to Observe Strong ... Digital Journal
Sanofi, Regeneron launch new Dupixent asthma TV ad urging ... FiercePharma
Drug developer QurAlis raises $88 mln in Sanofi-backed funding ... Reuters
Sepsis - Pipeline Insight, 2022: Innovations from SciClone, Sanofi ... businesswire.com
public companies who own 60% along with institutions invested in Sanofi India Limited (NSE:SANOFI) saw increase in their holdings value last week Simply Wall St
Sanofi (SNY) Dips More Than Broader Markets: What You Should ... Nasdaq
Sanofi India shares clock biggest intraday gain in 7 months on robust bottomline Moneycontrol
Acer Therapeutics' Product Acquired From Sanofi Fails In Menopause Study Yahoo Finance
Sanofi (SNY), Regeneron Dupixent sBLA Accepted for FDA Review Nasdaq
Zacks.com featured highlights Sanofi, SK Telecom, PBF Energy, Arrow Electronics and Novartis Yahoo Finance
Pakistan defers decision on drug price rise as pharma firms struggle Marketscreener.com
Zacks Industry Outlook Highlights J&J, Novo Nordisk, AstraZeneca ... Nasdaq
SGEN Stock Rockets On $43 Billion Takeover; Sanofi Buys Provention Investor's Business Daily
Lilly wants to treat diabetes differently with new campaign FiercePharma
Amgen Reply Brief Addresses Mischaracterizations by Sanofi, U.S. ... IPWatchdog.com
Patently Strategic: SCOTUS in Focus - Amgen v. Sanofi and the ... IPWatchdog.com
Novo's high-dose Rybelsus win tees up filings?and rivalries FiercePharma
A Look Into Sanofi's Debt - Sanofi (NASDAQ:SNY) Benzinga
What Do Sanofi And Dexcom See In DarioHealth That The Market Is Missing? Marketscreener.com
Eyeing Lilly, Novartis touts broader adjuvant breast cancer win FiercePharma
Sinusitis Market to Witness Growth by 2032, Estimates DelveInsight ... Digital Journal
White House sheds light on biomanufacturing push FiercePharma
Dividend Stocks: These 2 companies announce 3900% dividend to shareholders Zee Business
Targeted Drug Delivery Market Is Estimated To Grow During 2022 ... Digital Journal
Chronic Myeloid Leukemia Market to Exhibit Significant Growth as Leading Companies Such as Novartis, Ascentage Pharma, Terns Pharmaceuticals, Sanofi, and Others are Exploring the Domain | DelveInsight Yahoo Finance
Asthma Market to Observe Impressive Growth by 2032, Evaluates ... GlobeNewswire
First Hawaiian Bank Has $6.66 Million Stock Holdings in Sanofi ... MarketBeat
Herpes Simplex Virus (HSV) Vaccines Market will Offer Increased ... Digital Journal
Adult Vaccines Market Set for More Growth | GlaxoSmithKline, Sanofi Pasteur, Merck, Novartis openPR
Interleukin Inhibitors Market to Witness Huge Growth by 2029 ... Digital Journal
Sanofi?s enzyme replacement therapy available on NHS to Pompe ... PMLiVE
Class 2 Medicines Recall: Aventis Pharma Limited (t/a Sanofi ... GOV.UK
Signed order Sanofi International Biotech Company Ltd. GOV.UK
GSK and Sanofi shares surge after Zantac ruling victory Financial Times
Sanofi Pasteur COVID-19 vaccine authorised by MHRA GOV.UK
Sanofi and Innate Pharma expand cancer therapeutics collaboration PMLiVE
UK at risk of losing healthcare innovation race with European rivals ... Financial Times
Decision on Sanofi Ltd GOV.UK
Sanofi announces change in R&D leadership Science Business
Sanofi and Regeneron face a high-risk test for Dupixent evaluate.com
Is Sanofi's Stock Performance Being Led By Robust Fundamentals? Simply Wall St
Sanofi: The arrival of the 'haute couture' supply chain Supply Chain Digital
Sanofi trade union network building constructive relationship with ... IndustriALL Global Union
Sanofi trudges through tough quarter as vaccine sales slip FiercePharma
Exclusive: Sanofi to let go of staff at vaccine plants in India as part of ... Reuters.com
Sanofi and Sobi?s once-weekly haemophilia A treatment approved ... PMLiVE
Sanofi/Regeneron?s Dupixent approved by EC for eosinophilic ... PMLiVE
Sanofi CFO says stock price pummelling grossly overdone Reuters
Sanofi forecasts moderate profit growth on Dupixent demand Reuters.com
Big Pharma divided? Pfizer, AZ, Lilly and more support Sanofi in ... FiercePharma
Sanofi pulls phase 3 trial of $3.7B drug as competition heats up FierceBiotech
Sanofi offers refunds for Cablivi in novel model for rebates Pharmaceutical Technology
JPM23: Sanofi has reached the 'steady state' Paul Hudson ... FiercePharma
Sanofi/ Regeneron?s Dupixent recommended by CHMP to treat ... PMLiVE
Sanofi started?and lost?$28B bidding war for Horizon. Is the ... FiercePharma
Sanofi and Regeneron?s Dupixent granted EC approval for prurigo ... PMLiVE
Sanofi moves into swanky new Paris headquarters FiercePharma
AstraZeneca, Sanofi tee up 3-way RSV battle in 2023 as FDA ... FiercePharma
Sanofi inks 5-year deal with Thread to adopt more technology into ... FierceBiotech
GSK takes a cue from Sanofi with plans for a new headquarters FiercePharma
Glooko, Sanofi announce partnership to support diabetes patients Medical Device Network
GSK, Sanofi, Takeda sign with Singapore partnership to advance ... FiercePharma
Surprise, Skepticism And Scorn: Reaction To Rumored Haleon ... HBW Insight
Stocks to Watch in Europe: Chipmakers, Sanofi, Zur Rose Bloomberg
| For more news about SANOFI click here:
SANOFI News |
|
Website Width:
Background image: |
|  | |
|
|
![SANOFI - [Ticker: SAN.PA] chart](http://www.tr4der.com/intraday-chart/tr4der-SAN.PA.png)
